Literature DB >> 18718114

Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.

Vikram R Shinde1, Makarand R Shelake, Sandeep S Shetty, Amit B Chavan-Patil, Yogesh V Pore, Sameer G Late.   

Abstract

The solid-state properties and dissolution behaviour of lamotrigine in its inclusion complex with beta-cyclodextrin (betaCD) and solid dispersions with polyvinylpyrrolidone K30 (PVP K30) and polyethyleneglycol 6000 were investigated. The phase solubility profile of lamotrigine with betaCD was classified as AL-type, indicating formation of a 1:1 stoichiometry inclusion complex, with a stability constant of 369.96+/-2.26 M(-1). Solvent evaporation and kneading methods were used to prepare solid dispersions and inclusion complexes, respectively. The interaction of lamotrigine with these hydrophilic carriers was evaluated by powder X-ray diffractometry, Fourier transform infrared spectroscopy and differential scanning calorimetry. These studies revealed that the drug was no longer present in crystalline state but was converted to an amorphous form. Among the binary systems tested, PVP K30 (1:5) showed greatest enhancement of the solubility and dissolution of lamotrigine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718114     DOI: 10.1211/jpp.60.9.0002

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Improvement of physicochemical properties of an antiepileptic drug by salt engineering.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Raghu Samy; Vilayat A Sayeed; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2012-05-17       Impact factor: 3.246

2.  Safety of an intravenous formulation of lamotrigine.

Authors:  Jeannine M Conway; Angela K Birnbaum; Ilo E Leppik; Page B Pennell; James R White; John O Rarick; Rory P Remmel
Journal:  Seizure       Date:  2014-01-31       Impact factor: 3.184

3.  Application of hot melt extrusion to enhance the dissolution and oral bioavailability of oleanolic acid.

Authors:  Nannan Gao; Mengran Guo; Qiang Fu; Zhonggui He
Journal:  Asian J Pharm Sci       Date:  2016-08-04       Impact factor: 6.598

4.  Bimodal gastroretentive drug delivery systems of lamotrigine: formulation and evaluation.

Authors:  R R Poonuru; C S R Gonugunta
Journal:  Indian J Pharm Sci       Date:  2014 Nov-Dec       Impact factor: 0.975

5.  In vitro and in vivo evaluation of fast-dissolving tablets containing solid dispersion of lamotrigine.

Authors:  Arti Mohan; Rohit Gundamaraju
Journal:  Int J Pharm Investig       Date:  2015 Jan-Mar

6.  Inclusion complexes of cefuroxime axetil with β-cyclodextrin: Physicochemical characterization, molecular modeling and effect of l-arginine on complexation.

Authors:  Sarika Sapte; Yogesh Pore
Journal:  J Pharm Anal       Date:  2016-04-01

7.  Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity.

Authors:  Rita Ambrus; Péter Gieszinger; Róbert Gáspár; Anita Sztojkov-Ivanov; Eszter Ducza; Árpád Márki; Tamás Janáky; Ferenc Tömösi; Gábor Kecskeméti; Piroska Szabó-Révész; Csilla Bartos
Journal:  Molecules       Date:  2020-02-27       Impact factor: 4.411

8.  Formulation and clinical investigation of optimized vinpocetine lyoplant-tabs: new strategy in development of buccal solid dosage form.

Authors:  Tarek A Ahmed
Journal:  Drug Des Devel Ther       Date:  2018-12-28       Impact factor: 4.162

9.  A Solid Dispersion of Quercetin Shows Enhanced Nrf2 Activation and Protective Effects against Oxidative Injury in a Mouse Model of Dry Age-Related Macular Degeneration.

Authors:  Yan Shao; Haitao Yu; Yan Yang; Min Li; Li Hang; Xinrong Xu
Journal:  Oxid Med Cell Longev       Date:  2019-11-07       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.